Sign In
Buy DNLI
$19.66
+0.310 (+1.60%)
At Close: Jun 03, 2026
The Dow Jones Industrial Average Just Had Its Worst Day Since 1987. Yes, You Can Call It Panic.
09:46pm, Thursday, 12'th Mar 2020
The Dow Jones Industrial Average tumbled 2353 points, or 10%, on Thursday, its worst drop since 1987, and some Treasuries fell too.
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
01:00pm, Thursday, 12'th Mar 2020
Flagship Pioneering, a life sciences innovation enterprise, announced the launch of Repertoire Immune Medicines, a clinical-stage biotechnology compan
Charles Schwab Investment Management Inc. Has $6.52 Million Holdings in Denali Therapeutics Inc (NASDAQ:DNLI)
10:42am, Thursday, 12'th Mar 2020
Charles Schwab Investment Management Inc. raised its holdings in shares of Denali Therapeutics Inc (NASDAQ:DNLI) by 2.0% during the fourth quarter, according to the company in its most recent 13F fili
Denali Therapeutics Inc (NASDAQ:DNLI) Shares Purchased by Barclays PLC
09:26am, Thursday, 12'th Mar 2020
Barclays PLC lifted its holdings in Denali Therapeutics Inc (NASDAQ:DNLI) by 9.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Reaffirmed by Nomura
06:48am, Wednesday, 11'th Mar 2020
Denali Therapeutics (NASDAQ:DNLI)‘s stock had its “buy” rating reissued by equities research analysts at Nomura in a report released on Monday, AnalystRatings.com reports. They presently have a
Denali Therapeutics Inc (NASDAQ:DNLI) Expected to Post Quarterly Sales of $5.93 Million
06:58am, Tuesday, 10'th Mar 2020
Wall Street analysts expect that Denali Therapeutics Inc (NASDAQ:DNLI) will announce $5.93 million in sales for the current quarter, according to Zacks. Six analysts have provided estimates for Denali
Comparing Repligen (NASDAQ:RGEN) and Denali Therapeutics (NASDAQ:DNLI)
06:02am, Tuesday, 10'th Mar 2020
Repligen (NASDAQ:RGEN) and Denali Therapeutics (NASDAQ:DNLI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitabilit
Nomura Maintains Their Buy Rating on Denali Therapeutics (DNLI)
05:06pm, Monday, 09'th Mar 2020
Nomura analyst Christopher Marai maintained a Buy rating on Denali Therapeutics (DNLI) on March 4 and set a price target of $35.00. The company's shares
Nomura Maintains Their Buy Rating on Denali Therapeutics (DNLI)
05:06pm, Monday, 09'th Mar 2020
Nomura analyst
Christopher Marai
maintained a
Buy
rating on Denali Therapeutics (
DNLI
–
Research Report
) on March 4 and set a price target of
$35.00
. The company’s shares closed last Monday at
Denali Therapeutics (NASDAQ:DNLI) Stock Rating Lowered by Zacks Investment Research
07:53am, Saturday, 07'th Mar 2020
Zacks Investment Research downgraded shares of Denali Therapeutics (NASDAQ:DNLI) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com reports. Accord
Denali Therapeutics (NASDAQ:DNLI) Lifted to Strong-Buy at ValuEngine
07:56am, Tuesday, 03'rd Mar 2020
Denali Therapeutics (NASDAQ:DNLI) was upgraded by equities researchers at ValuEngine from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday, ValuEngine reports. Othe
Denali Therapeutics (DNLI) Gets a Buy Rating from H.C. Wainwright
12:07pm, Monday, 02'nd Mar 2020
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Denali Therapeutics (DNLI) today and set a price target of $28.00. The company's shares
Denali Therapeutics Inc (NASDAQ:DNLI) Receives Consensus Recommendation of "Buy" from Brokerages
09:34am, Monday, 02'nd Mar 2020
Denali Therapeutics Inc (NASDAQ:DNLI) has received a consensus recommendation of “Buy” from the twelve analysts that are covering the firm, Marketbeat Ratings reports. One equities research analys
Denali Therapeutics Inc (NASDAQ:DNLI) Major Shareholder Sells $78,868,971.00 in Stock
09:18am, Monday, 02'nd Mar 2020
Denali Therapeutics Inc (NASDAQ:DNLI) major shareholder Douglas K. Bratton sold 3,894,764 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The shares were s
Financial Review: Axcella Health (NASDAQ:AXLA) and Denali Therapeutics (NASDAQ:DNLI)
07:34am, Sunday, 01'st Mar 2020
Axcella Health (NASDAQ:AXLA) and Denali Therapeutics (NASDAQ:DNLI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of
